142 related articles for article (PubMed ID: 1541343)
1. Establishment of a naphthalene cataract model in vitro.
Xu GT; Zigler JS; Lou MF
Exp Eye Res; 1992 Jan; 54(1):73-81. PubMed ID: 1541343
[TBL] [Abstract][Full Text] [Related]
2. The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (ALO1576).
Xu GT; Zigler JS; Lou MF
Exp Eye Res; 1992 Jan; 54(1):63-72. PubMed ID: 1541342
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of naphthalene cataract in rats by aldose reductase inhibitors.
Lou MF; Xu GT; Zigler S; York B
Curr Eye Res; 1996 Apr; 15(4):423-32. PubMed ID: 8670742
[TBL] [Abstract][Full Text] [Related]
4. Prevention of naphthalene-1,2-dihydrodiol-induced lens protein modifications by structurally diverse aldose reductase inhibitors.
Sato S; Sugiyama K; Lee YS; Kador PF
Exp Eye Res; 1999 May; 68(5):601-8. PubMed ID: 10328974
[TBL] [Abstract][Full Text] [Related]
5. Naphthalene-induced cataract in the rat. II. Contrasting effects of two aldose reductase inhibitors on glutathione and glutathione redox enzymes.
Tao RV; Holleschau AM; Rathbun WB
Ophthalmic Res; 1991; 23(5):272-83. PubMed ID: 1784459
[TBL] [Abstract][Full Text] [Related]
6. Involvement of aldose reductase in naphthalene cataract.
Lee AY; Chung SS
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):193-7. PubMed ID: 9430562
[TBL] [Abstract][Full Text] [Related]
7. Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat.
Tao RV; Takahashi Y; Kador PF
Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1630-7. PubMed ID: 1901836
[TBL] [Abstract][Full Text] [Related]
8. alpha-Lipoic acid alters post-translational modifications and protects the chaperone activity of lens alpha-crystallin in naphthalene-induced cataract.
Chen Y; Yi L; Yan G; Fang Y; Jang Y; Wu X; Zhou X; Wei L
Curr Eye Res; 2010 Jul; 35(7):620-30. PubMed ID: 20597648
[TBL] [Abstract][Full Text] [Related]
9. Prevention of acetaminophen- and naphthalene-induced cataract and glutathione loss by CySSME.
Rathbun WB; Holleschau AM; Cohen JF; Nagasawa HT
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):923-9. PubMed ID: 8603877
[TBL] [Abstract][Full Text] [Related]
10. Dynamic phosphorus-31 NMR study of sugar cataract and its prevention in rat lenses with aldose reductase inhibitors.
Thomas DM; Mahendroo PP; Lou MF
Exp Eye Res; 1988 Jan; 46(1):37-47. PubMed ID: 3125056
[TBL] [Abstract][Full Text] [Related]
11. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
[TBL] [Abstract][Full Text] [Related]
12. Cataract development induced by repeated oral dosing with FK506 (tacrolimus) in adult rats.
Ishida H; Mitamura T; Takahashi Y; Hisatomi A; Fukuhara Y; Murato K; Ohara K
Toxicology; 1997 Dec; 123(3):167-75. PubMed ID: 9355935
[TBL] [Abstract][Full Text] [Related]
13. Dietary curcumin prevents ocular toxicity of naphthalene in rats.
Pandya U; Saini MK; Jin GF; Awasthi S; Godley BF; Awasthi YC
Toxicol Lett; 2000 Jun; 115(3):195-204. PubMed ID: 10814889
[TBL] [Abstract][Full Text] [Related]
14. Aldose reductase the major protein associated with naphthalene dihydrodiol dehydrogenase activity in rat lens.
Sato S
Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3172-8. PubMed ID: 8407226
[TBL] [Abstract][Full Text] [Related]
15. Cataractogenicity and bioactivation of naphthalene derivatives in lens culture and in vivo.
Lubek BM; Kubow S; Basu PK; Wells PG
Lens Eye Toxic Res; 1989; 6(1-2):203-9. PubMed ID: 2562167
[TBL] [Abstract][Full Text] [Related]
16. Decreased chaperone activity of alpha-crystallins in naphthalene-induced cataract possibly results from C-terminal truncation.
Chen Y; Yi L; Yan GQ; Jang YX; Fang YW; Wu XH; Zhou XW; Wei LM
J Int Med Res; 2010; 38(3):1016-28. PubMed ID: 20819438
[TBL] [Abstract][Full Text] [Related]
17. Nerve growth factor (NGF) and lenses: effects of NGF in an in vitro rat model of cataract.
Ghinelli E; Aloe L; Cortes M; Micera A; Lambiase A; Bonini S
Graefes Arch Clin Exp Ophthalmol; 2003 Oct; 241(10):845-51. PubMed ID: 13680251
[TBL] [Abstract][Full Text] [Related]
18. Effect of an aldose reductase inhibitor, AL-1576, on the development of UV-B and X-ray cataract.
Schmitt C; Schmidt J; Wegener A; Hockwin O
Graefes Arch Clin Exp Ophthalmol; 1988; 226(5):455-60. PubMed ID: 3142804
[TBL] [Abstract][Full Text] [Related]
19. Naphthalene-induced cataract model in rats: A comparative study between slit and retroillumination images, biochemical changes and naphthalene dose and duration.
Holmén JB; Ekesten B; Lundgren B
Curr Eye Res; 1999 Nov; 19(5):418-25. PubMed ID: 10520218
[TBL] [Abstract][Full Text] [Related]
20. Glutathione synthesis and glutathione redox pathways in naphthalene cataract of the rat.
Rathbun WB; Holleschau AM; Murray DL; Buchanan A; Sawaguchi S; Tao RV
Curr Eye Res; 1990 Jan; 9(1):45-53. PubMed ID: 1968827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
